These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37859587)

  • 1. Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi-site pilot trial.
    Cochran G; Smid MC; Krans EE; Yu Z; Carlston K; White A; Abdulla W; Baylis J; Charron E; Okifugi A; Gordon AJ; Lundahl B; Silipigni J; Seliski N; Haaland B; Tarter R
    Addiction; 2024 Mar; 119(3):544-556. PubMed ID: 37859587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot multisite study of patient navigation for pregnant women with opioid use disorder.
    Cochran G; Smid MC; Krans EE; Bryan MA; Gordon AJ; Lundahl B; Silipigni J; Haaland B; Tarter R
    Contemp Clin Trials; 2019 Dec; 87():105888. PubMed ID: 31731006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study.
    Cochran GT; Hruschak V; Abdullah W; Krans E; Douaihy AB; Bobby S; Fusco R; Tarter R
    J Addict Med; 2018; 12(1):72-79. PubMed ID: 29140822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C
    JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention.
    Rinehart DJ; Stowell M; Collings A; Durfee MJ; Thomas-Gale T; Jones HE; Binswanger I
    J Subst Abuse Treat; 2021 Jul; 126():108318. PubMed ID: 34116817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
    Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
    Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of extended-release naltrexone with or without patient navigation vs enhanced treatment-as-usual for incarcerated adults with opioid use disorder.
    Farabee D; Condon T; Hallgren KA; McCrady B
    J Subst Abuse Treat; 2020 Oct; 117():108076. PubMed ID: 32811623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial.
    Whiteside LK; Huynh L; Morse S; Hall J; Meurer W; Banta-Green CJ; Scheuer H; Cunningham R; McGovern M; Zatzick DF
    J Subst Abuse Treat; 2022 May; 136():108666. PubMed ID: 34952745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
    Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
    Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in opioid use disorder-related hospital use among postpartum Virginia Medicaid members.
    Martin CE; Britton E; Shadowen H; Bachireddy C; Harrell A; Zhao X; Cunningham P
    J Subst Use Addict Treat; 2023 Feb; 145():208935. PubMed ID: 36880911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder.
    Work EC; Muftu S; MacMillan KDL; Gray JR; Bell N; Terplan M; Jones HE; Reddy J; Wilens TE; Greenfield SF; Bernstein J; Schiff DM
    Matern Child Health J; 2023 Dec; 27(Suppl 1):104-112. PubMed ID: 37253899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.
    Curran L; Manuel J
    Int J Drug Policy; 2024 Apr; 126():104342. PubMed ID: 38479161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial.
    Winhusen T; Wilder C; Kropp F; Theobald J; Lyons MS; Lewis D
    Drug Alcohol Depend; 2020 Nov; 216():108270. PubMed ID: 32911132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics.
    Forray A; Mele A; Byatt N; Londono Tobon A; Gilstad-Hayden K; Hunkle K; Hong S; Lipkind H; Fiellin DA; Callaghan K; Yonkers KA
    PLoS One; 2022; 17(1):e0261751. PubMed ID: 35025898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.
    Schramm ZA; Leroux BG; Radick AC; Ventura AS; Klein JW; Samet JH; Saxon AJ; Kim TW; Tsui JI
    Addict Sci Clin Pract; 2020 Jul; 15(1):30. PubMed ID: 32736660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse.
    Greiner MG; Shulman M; Choo TH; Scodes J; Pavlicova M; Campbell ANC; Novo P; Fishman M; Lee JD; Rotrosen J; Nunes EV
    J Subst Abuse Treat; 2021 Dec; 131():108447. PubMed ID: 34098301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Use Disorder and Overdose in the First Year Postpartum: A Rapid Scoping Review and Implications for Future Research.
    Frankeberger J; Jarlenski M; Krans EE; Coulter RWS; Mair C
    Matern Child Health J; 2023 Jul; 27(7):1140-1155. PubMed ID: 36840785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021.
    Miele K; Kim SY; Jones R; Rembert JH; Wachman EM; Shrestha H; Henninger ML; Kimes TM; Schneider PD; Sivaloganathan V; Sward KA; Deshmukh VG; Sanjuan PM; Maxwell JR; Seligman NS; Caveglia S; Louis JM; Wright T; Bennett CC; Green C; George N; Gosdin L; Tran EL; Meaney-Delman D; Gilboa SM
    MMWR Surveill Summ; 2023 May; 72(3):1-14. PubMed ID: 37130060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.